From a regulatory point of view, medication reconciliation is a necessary process to ensure safe medication management for patients. According to national studies and the international scientific literature, the information received by patients and health professionals at discharge from hospital is insufficient. Medication reconciliation at discharge reduces medication errors and rehospitalisation, but few studies have been conducted on the impact of a coordinated and reliable care pathway on medication continuity. The iCoCon study will enable a new healthcare organisation to be set up in order to improve the quality of the patient pathway and the patient's medication management. This new organisation is part of the policy of continuous improvement of the quality and safety of care
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
130
Drug reconciliation information transmission to pharmacist interview with the patient
Centre Hospitalier Du Mans
Le Mans, France
RECRUITINGValue of a coordinated and reliable pathway when patients are discharged from the institution via drug reconciliation to ensure the continuity of patients' treatment
Value of coordinated pathway is evaluated by number of days of treatment interruption between patient discharge and provision of treatment to the patient
Time frame: 1 month after inclusion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.